- Home
- MASI
MASI
Masimo Corporation
as 09-12-2025 4:00pm EST
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 8.1B | IPO Year: | 2007 |
| Target Price: | $194.60 | AVG Volume (30 days): | 587.8K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $111.03 - $194.88 | Next Earning Date: | 11-04-2025 |
| Revenue: | $2,153,800,000 | Revenue Growth: | 25.86% |
| Revenue Growth (this year): | -25.95% | Revenue Growth (next year): | 7.80% |
Stock Insider Trading Activity of Masimo Corporation (MASI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Brennan Michelle | MASI | N/A | Aug 13 '25 | Buy | $155.25 | 100 | $15,525.00 | 7,318 | |
| Brennan Michelle | MASI | N/A | Aug 12 '25 | Buy | $150.35 | 100 | $15,035.00 | 7,318 | |
| Jellison William R | MASI | N/A | Aug 11 '25 | Buy | $145.98 | 3,000 | $437,940.00 | 4,790 |
Latest Masimo Corporation News
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
Insider Monkey
8 days ago
Apple Watch (AAPL) Blood Oxygen Feature Reintroduced in US After Legal Battle
Zacks
8 days ago
Is it the Right Time to Add CRL Stock to Your Portfolio Now?
StockStory
3 months ago
The 5 Most Interesting Analyst Questions From Masimo’s Q1 Earnings Call
StockStory
3 months ago
3 Unprofitable Stocks with Questionable Fundamentals
Argus Research
3 months ago
MASI: Raising target price to $176.00
Business Wire
3 months ago
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
StockStory
3 months ago
3 Reasons MASI is Risky and 1 Stock to Buy Instead
StockStory
3 months ago
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
Compare MASI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.